Luis Diaz Quintero
Cardiovascular Disease · Chicago, ILNPI 1437506557
Payments from drug & device makers
What this record shows
This record is dominated by grants: $19,667 of the $27,391 with a category attached, or 71.8%. Boston Scientific accounts for 64.9% of it on its own, with 16 other manufacturers making up the rest. 2025 is the largest year on record at $18,687, more than ten times the $21 reported in 2019. Among cardiovascular disease clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 116 payments — averaging $236.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$18K
- Medtronic$4K
- Edwards Lifesciences$3K
- Abbott$2K
- Biosense Webster, Inc.$245
- Penumbra, Inc.$141
- plus $448 from 11 others
What the payments were for
- Grants$19,66772%
- Travel & lodging$3,69113%
- Food & beverage$3,66013%
- Education$3741%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 33 | $17,764 |
| Medtronic | 20 | $4,466 |
| Edwards Lifesciences | 23 | $2,651 |
| Abbott | 21 | $1,676 |
| Biosense Webster, Inc. | 2 | $245 |
| Penumbra, Inc. | 1 | $141 |
| Abiomed | 3 | $109 |
| Chiesi USA, Inc. | 1 | $70 |
| Asahi Intecc USA, Inc. | 2 | $56 |
| Cordis US CORP. | 3 | $48 |
| Lexicon Pharmaceuticals, Inc. | 1 | $28 |
| Kestra Medical Technology Services, Inc. | 1 | $26 |
| Cardiva Medical, Inc. | 1 | $25 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $24 |
| Heartflow, Inc. | 1 | $23 |
| AstraZeneca | 1 | $21 |
| GE HealthCare | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL - THERAPIES$16,667
- PASCAL$1,126
- COREVALVE EVOLUT R$1,032
- MitraClip$922
- ONYX FRONTIER$221
- Edwards SAPIEN 3 Transcatheter Heart Valve$208
- NUVISION ICE CATHETER$182
- EnSite Precision Cardiac Mapping System$151
- General - Balloon Catheters$142
- Indigo System$141
- AVVIGO Guidance System$141
- STINGRAY$125
- XIENCE SKYPOINT$116
How this compares
$27,391 in reported general payments places this provider in the 90th percentile of 932 cardiovascular disease providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 13 | $15,553 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Chicago
- Sandeep NathanChicago$892K
- Boaz AvitallChicago$366K
- Akhil NarangChicago$363K
- Michael DavidsonChicago$317K
- Jyothy PuthumanaChicago$269K
- Sanjiv ShahChicago$246K
- Raja MutharasanChicago$146K
- Nitasha SarswatChicago$140K
- Evan SteinChicago$121K
- Dan FintelChicago$119K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.